# Blood Test for Breast Cancer Associated Auto Antibodies - Improvement of Octava Blood Test

> **NCT02066025** · — · UNKNOWN · sponsor: **Eventus Diagnostics Ltd** · enrollment: 1425 (estimated)

## Conditions studied

- Breast Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02066025
- **Lead sponsor:** Eventus Diagnostics Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-03
- **Primary completion:** 2016-03
- **Final completion:** 2018-03
- **Target enrollment:** 1425 (ESTIMATED)
- **Last updated:** 2014-02-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02066025

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02066025, "Blood Test for Breast Cancer Associated Auto Antibodies - Improvement of Octava Blood Test". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT02066025. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*